Renal sympathetic denervation in patients with treatment-resistant hypertension (The Symplicity HTN-2 Trial): a randomised controlled trialRoland E. Schmieder, Murray Esler, Henry Krum et al.|The Lancet|2010Cited by 2.2k
Catheter-based renal sympathetic denervation for resistant hypertension: a multicentre safety and proof-of-principle cohort studyHenry Krum, Murray Esler, Markus P. Schlaich et al.|The Lancet|2009Cited by 2.1k
Effect of interleukin-1β inhibition with canakinumab on incident lung cancer in patients with atherosclerosis: exploratory results from a randomised, double-blind, placebo-controlled trialPaul M. Ridker, Hakan Kültürsay, Alberto Lorenzatti et al.|The Lancet|2017Cited by 1.3k
Targeted Anticytokine Therapy in Patients With Chronic Heart FailureDouglas L. Mann, Thomas R. Fleming, John J.V. McMurray et al.|Circulation|2004Cited by 1.2k
Aliskiren, ALTITUDE, and the Implications for ATMOSPHEREJohn J.V. McMurray, Henry Krum, William T. Abraham et al.|European Journal of Heart Failure|2012Cited by 1.1k